CLINUVEL Expands DNA Repair Program with 2nd DNA Repair Study 2022 Announcements . Clinical . News 14.02.2022
CLINUVEL completes enrolment in world-first stroke study 2022 Announcements . Clinical . News 17.01.2022
First Patient Treated in CLINUVEL DNA Repair Study 2021 Announcements . Clinical . Corporate 22.10.2021
Afamelanotide well tolerated by first stroke patients 2021 Announcements . Clinical . News 10.08.2021
Media Release – First stroke patient treated with afamelanotide 2021 Announcements . Clinical . News 07.06.2021
Media Release – CLINUVEL Expands DNA Repair Program 2021 Announcements . Clinical . Corporate . News 24.03.2021
SCENESSE® To Be Evaluated in Xeroderma Pigmentosum Variant (XPV) 2021 Announcements . Clinical . Corporate . Regulatory 24.03.2021
SCENESSE® Granted Market Access In Israel 2021 Announcements . Clinical . Corporate . Regulatory 11.02.2021
SCENESSE® DNA REPAIR STUDY IN HEALTHY VOLUNTEERS APPROVED 2020 Announcements . Clinical . Corporate 30.11.2020